Axsome Therapeutics, Inc. Earnings

Axsome Therapeutics, Inc.’s revenue jumped 61.95% since last year same period to $121.46Mn in the Q1 2025. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 2.27% jump in its revenue since last 3-months.

Axsome Therapeutics, Inc.’s net profit jumped 13.08% since last year same period to $-59.41Mn in the Q1 2025. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 20.69% jump in its net profits since last 3-months.

Axsome Therapeutics, Inc.’s net profit margin jumped 46.33% since last year same period to -48.91% in the Q1 2025. On a quarterly growth basis, Axsome Therapeutics, Inc. has generated 22.45% jump in its net profit margins since last 3-months.

Axsome Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.05 - a 13.22% jump from last quarter’s estimates.

Axsome Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.05.

Axsome Therapeutics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Axsome Therapeutics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.